A Far Downstream Enhancer for Murine Bcl11b Controls Its T-cell Specific Expression
Overview
Authors
Affiliations
Bcl11b is a T-cell specific gene in hematopoiesis that begins expression during T-lineage commitment and is required for this process. Aberrant expression of BCL11B or proto-oncogene translocation to the vicinity of BCL11B can be a contributing factor in human T-ALL. To identify the mechanism that controls its distinctive T-lineage expression, we corrected the identified Bcl11b transcription start site and mapped a cell-type-specific differentially methylated region bracketing the Bcl11b promoter. We identified a 1.9-kb region 850 kb downstream of Bcl11b, "Major Peak," distinguished by its dynamic histone marking pattern in development that mirrors the pattern at the Bcl11b promoter. Looping interactions between promoter-proximal elements including the differentially methylated region and downstream elements in the Major Peak are required to recapitulate the T-cell specific expression of Bcl11b in stable reporter assays. Functional dissection of the Major Peak sequence showed distinct subregions, in which TCF-1 sites and a conserved element were required for T-lineage-specific activation and silencing in non-T cells. A bacterial artificial chromosome encompassing the full Bcl11b gene still required the addition of the Major Peak to exhibit T-cell specific expression. Thus, promoter-proximal and Major Peak sequences are cis-regulatory elements that interact over 850 kb to control expression of Bcl11b in hematopoietic cells.
Analysis of the Transcriptional Control of in Chicken: IRF1 and GATA1 as Negative Regulators.
Qiu L, Wang H, Li W, Yang T, Bai H, Chang G Animals (Basel). 2025; 15(5).
PMID: 40075948 PMC: 11898421. DOI: 10.3390/ani15050665.
A timed epigenetic switch balances T and ILC lineage proportions in the thymus.
Pease N, Denecke K, Chen L, Gerges P, Kueh H Development. 2024; 151(23.
PMID: 39655434 PMC: 11664168. DOI: 10.1242/dev.203016.
RNA-Independent Regulatory Functions of lncRNA in Complex Disease.
Kafida M, Karela M, Giakountis A Cancers (Basel). 2024; 16(15).
PMID: 39123456 PMC: 11311644. DOI: 10.3390/cancers16152728.
Super-enhancer omics in stem cell.
Ma H, Qu J, Pang Z, Luo J, Yan M, Xu W Mol Cancer. 2024; 23(1):153.
PMID: 39090713 PMC: 11293198. DOI: 10.1186/s12943-024-02066-z.
Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy.
Singh V, Nandi S, Ghosh A, Adhikary S, Mukherjee S, Roy S Cancer Metastasis Rev. 2024; 43(1):175-195.
PMID: 38233727 DOI: 10.1007/s10555-024-10167-w.